Table of contents
- COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
- VitaminDWiki -
12 studies in both categories Virus and MS - People with Multiple Sclerosis have learned to take Vitamin D
- Suspect that many MSers taking lots of vitamin D never even entered the hospital
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
Mult Scler Relat Disord. 2022 Jun 6;63:103946. doi: 10.1016/j.msard.2022.103946
Sarah E Conway 1, Brian C Healy 2, Jonathan Zurawski 1, Christopher Severson 1, Tamara Kaplan 1, Lynn Stazzone 1, Kristin Galetta 1, Tanuja Chitnis 1, Maria K Houtchens 336% got worse
Trends: Take more vitamin D ==> fewer COVID problems
Background: Neurologic outcomes in patients with multiple sclerosis (MS) and related disorders (MSRD) following COVID-19 is not well understood. The objective of this study was to investigate neurologic outcomes in patients with MSRD post-COVID-19.Methods: This was a retrospective medical records review study of adult patients with MSRD and COVID-19 infection at the Brigham MS Center. Neurologic worsening post-COVID-19 was defined as having a relapse, pseudorelapse, new brain MRI activity, worsening of preexisting MSRD symptoms, or development of other long-term neurologic symptoms.
Results: 111 patients, 85 (76.6%) females, with a mean [SD] age of 49.3 [12.2] years and median [range] EDSS of 2.5 [0, 8.5] were identified. 41 patients (36.9%) had neurologic worsening post-COVID-19. Of those, 19 (46.3%) had pseudorelapses, 2 (4.8%) had relapses, and 24 (58.5%) patients reported worsening of preexisting MSRD symptoms, or other new long-term neurologic symptoms. Neurologic worsening was associated with hospitalized (moderate or severe) COVID-19 (p = 0.001), treatment for COVID-19 (p = 0.006), and incomplete COVID-19 recovery (p = 0.0267) but not with age, sex, MS type, race, disease duration, EDSS, vitamin D use, or disease modifying therapy use.
Conclusions: COVID-19 severity and lack of complete systemic recovery were associated with new or worsening neurologic symptoms in 36.9% of MSRD patients.
 Download the PDF from VitaminDWiki
VitaminDWiki -
12 studies in both categories Virus and MS This list is automatically updated
- COVID infections or vaccinations may increase Multiple Sclerosis (if low D) - several studies
- Autoimmune diseases caused in first day after COVID Vaccination - Oct 2023
- Epstein-Barr Virus may be a prerequisite for Multiple Sclerosis - July 2023
- Diseases treated by high-dose Vitamin D - many studies
- 36% of Multiple Sclerosis patients got worse after mild to severe COVID– June 2022
- Multiple Sclerosis Risk factors include virus such as Human Herpesvirus 6A – many studies
- Epstein-Barr virus increases risk of Multiple Sclerosis by 32X - Jan 2022
- COVID death rate was 3X lower in those with Multiple Sclerosis (85 pcnt were taking Vitamin D) - Jan 2022
- Multiple Sclerosis risk increased if both Epstein-Bar Virus and low sun (vitamin D) – Aug 2021
- Multiple Sclerosis patients had fewer COVID-19 problems (Note: many MSers take Vitamin D) – April 30, 2021
- Infectious mononucleosis and lack of UV linearly linked to MS in England – April 2011
- Multiple Sclerosis etc. strongly associated with Epstein-Barr virus (and vitamin D)
People with Multiple Sclerosis have learned to take Vitamin D
- Rate of vitamin D supplementation by Blacks increases 16X after getting Multiple Sclerosis – Feb 2018
- UK people with Multiple Sclerosis are 3X more likely to take Vitamin D - Oct 2020
- Multiple Sclerosis: 10 percent fewer relapses for each 10 ng higher level of vitamin D – Meta-analysis April 2020
Suspect that many MSers taking lots of vitamin D never even entered the hospital
- 53 Multiple Sclerosis patients somewhat helped by 10,000 IU of vitamin D (vs, 30,000 virtually cured by 10X as much) – Jan 2020
- Dr. Coimbra explains his treatment with high dose vitamin D for multiple sclerosis – Feb 2015
- Coimbra protocol using high-dose Vitamin D is safe – April 2022
- Multiple Sclerosis patients had fewer COVID-19 problems (Note: many MSers take Vitamin D) – April 30, 2021
36% of Multiple Sclerosis patients got worse after mild to severe COVID– June 20222383 visitors, last modified 17 Jun, 2022, This page is in the following categories (# of items in each category)Attached files
ID Name Uploaded Size Downloads 17894 MS COVID.jpg admin 17 Jun, 2022 47.36 Kb 169 17893 MS and COVID.jpg admin 17 Jun, 2022 44.02 Kb 169 17892 COVID and MS.pdf admin 17 Jun, 2022 533.89 Kb 191